What is the ROE (Return on Equity) of Medios this year?
The ROE of Medios this year is 0.04 undefined.
Medios ROE 2024
Medios ROE
0.04
Medios Dividend yield
Ticker
ILM1.DE
ISIN
DE000A1MMCC8
WKN
A1MMCC
In 2024, Medios's return on equity (ROE) was 0.04, a -1.92% increase from the 0.04 ROE in the previous year.
Medios Aktienanalyse
What does Medios do?
Medios AG is a leading company in the supply of high-quality specialty preparations to patients. The company was founded in Berlin in 2004 and has been listed on the Frankfurt Stock Exchange since 2018. Medios AG quickly achieved a strong position in the German healthcare market and currently employs approximately 300 employees at multiple locations in Germany. The business model of Medios AG is based on the production and distribution of high-quality specialty preparations. These are developed and produced in close collaboration with customers such as hospitals and outpatient clinics. Medios AG's products are typically used to treat rare and chronic diseases, such as immunological diseases, cancer, and metabolic disorders. Medios AG offers a wide range of products and services. The company is divided into three areas. The first area is Medios AG's core business, the distribution of specialty preparations. This area includes the development, production, and distribution of specialty preparations. The portfolio includes, for example, medications for pain and inflammation, as well as preparations for the treatment of Parkinson's and Alzheimer's diseases. Another important aspect in the field of specialty preparations is the supply of patients with parenteral nutrition solutions. These are used in both outpatient and inpatient settings to provide care for patients with severe diseases. The second area is supply services. Here, Medios offers a comprehensive range of services to support customers in hospital care and outpatient patient care. An important aspect of this area is the support of hospitals in dealing with delegations. For example, training is offered to educate hospital staff on the management of certain diseases. The third area is clinical study support. Medios AG offers services and products to support customers in clinical studies. The range includes criteria for patient-related logistics, the delivery of placebos and blinded medications, as well as specialty preparations and parenteral nutrition solutions. In each of these areas, Medios brings its high expertise and experience to develop the best possible solutions for customers and patients. Overall, Medios AG has established itself as an important partner for the German healthcare sector. The company pursues a clear strategy focused on the development and production of specialty preparations for the treatment of serious and rare diseases. The company places the highest value on the quality and safety of its products, as well as comprehensive consultation and customer care. Medios has a strong network of partners and suppliers in the healthcare industry and is a respected contact for customers and other market participants due to its experience and expertise. Medios ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROE Details
Decoding Medios's Return on Equity (ROE)
Medios's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.
Year-to-Year Comparison
Analyzing Medios's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.
Impact on Investments
Medios's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.
Interpreting ROE Fluctuations
Changes in Medios’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.
Frequently Asked Questions about Medios Stock
How has the Return on Equity (ROE) of Medios developed compared to the previous year?
The ROE of Medios has increased by -1.92% decreased compared to the previous year.
What impact does a high ROE (Return on Equity) have on investors of Medios?
A high ROE indicates that Medios generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.
What impact does a low ROE (Return on Equity) have on investors of Medios?
A low ROE can indicate that Medios is having difficulties monetizing its investments successfully and can be a negative signal for investors.
How does a change in the ROE (Return on Equity) of Medios affect the company?
A change in ROE (Return on Equity) of Medios can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.
How to calculate the ROE (Return on Equity) of Medios?
The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.
Which factors influence the ROE (Return on Equity) of Medios?
Some factors that can influence Medios's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.
What strategic measures can take to improve the ROE (Return on Equity)?
To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.
How much dividend does Medios pay?
Over the past 12 months, Medios paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Medios is expected to pay a dividend of 0 EUR.
What is the dividend yield of Medios?
The current dividend yield of Medios is .
When does Medios pay dividends?
Medios pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Medios?
Medios paid dividends every year for the past 0 years.
What is the dividend of Medios?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Medios located?
Medios is assigned to the 'Health' sector.
Wann musste ich die Aktien von Medios kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Medios from 5/15/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 5/15/2024.
When did Medios pay the last dividend?
The last dividend was paid out on 5/15/2024.
What was the dividend of Medios in the year 2023?
In the year 2023, Medios distributed 0 EUR as dividends.
In which currency does Medios pay out the dividend?
The dividends of Medios are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Medios
Our stock analysis for Medios Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Medios Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
